Full Press Release Details
Health Canada Marijuana License Application
Kelowna, BC September 17, 2014 - Lexaria Corp.
(LXRP-OTCQB) (LXX-CNSX) (the "Company" or "Lexaria") reports that the
joint venture with Enertopia Corp has submitted the Health Canada MMPR Licensed
Producer application in July 2014, and that the application is currently in the
Health Canada preliminary screening process. The actual submission of our
license application had not been previously disclosed.
The Joint Venture is in correspondence with Health Canada
frequently with respect to specific aspects of the licensing process which are
being handled by Ontario Operations Manager Mr. Donald Shaxon, responsible
person in charge. The Joint Venture has requested a Ready to Build letter from
The Burlington Joint Venture with Enertopia Corp (ENRT or TOP)
has applied to produce 10,000kg of Medical Marihuana per year under its Licensed
Producer application. Enertopia has 51% interest in the joint venture and
Lexaria Corp 49%, as earlier disclosed.
The Burlington JV has requested a Ready to build letter from
Health Canada once the application has been accepted from Health Canada.
Listed below are the Health Canada steps for becoming a
licensed producer to be reached by way of the application and review process.
There are no specific process time constraints for each step.
Step 1: Preliminary Screening
Step 2: Enhanced Screening
Step 3: Security Clearance
Step 5: Ready to build letter (if required by applicant)
Step 6: Pre-licence inspection
Health Canada has also been clear about the quantity of
licenses to be issued, in contrast to certain marketplace speculation. The
Health Canada website asks the question, Is there a limit to how many
production licences Health Canada will issue under the Marihuana for Medical
Purposes Regulations (MMPR)? And Health Canada answers the question with, No.
Health Canada will not impose a limit on the number of production licenses.
Lexaria provides the above information to provide guidance and
clarity to counter what at times appear to be flawed information in the
community, of course acknowledging that the policies of third parties can change
The Joint Venture has been active in the local community and
has met with the local policing authority, which is interested in conducting
security training and swat team training at the Joint Venture facility. We are
very pleased to be working closely with law enforcement and look forward to
learning more from preventative and proactive security measures.
Lexaria also notes that the Ottawa project has conducted due
diligence on and rejected the initial proposed building location in the greater
Ottawa area as not likely to comply with the strict requirements of the MMPR.
Additional locations in the area are being examined. The company will remain
prudent in its efforts to ensure the maximum return on all our stakeholder s
Lexaria s shares are quoted in the USA with symbol LXRP and in
Canada with symbol LXX. The company searches for projects that could provide
potential above-market returns.
To learn more about Lexaria Corp. visit
FOR FURTHER INFORMATION PLEASE CONTACT:
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements
which are not historical facts are forward-looking statements. The Company makes
forward-looking public statements concerning its expected future financial
position, results of operations, cash flows, financing plans, business strategy,
products and services, competitive positions, growth opportunities, plans and
objectives of management for future operations, including statements that
include words such as "anticipate," "if," "believe," "plan," "estimate,"
"expect," "intend," "may," "could," "should," "will," and other similar
expressions are forward-looking statements. Such forward-looking statements are
estimates reflecting the Company's best judgment based upon current information
and involve a number of risks and uncertainties, and there can be no assurance
that other factors will not affect the accuracy of such forward-looking
statements. Access to capital, or lack thereof, is a major risk and there is no
assurance that the Company will be able to raise required working capital.
Current oil and gas production rates may not be sustainable and targeted
production rates may not occur. Factors which could cause actual results to
differ materially from those estimated by the Company include, but are not
limited to, government regulation, managing and maintaining growth, the effect
of adverse publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements and filings.
There is no assurance that the medical marijuana business will provide any
benefit to Lexaria and no assurance that the corporate policies described herein
will produce any benefit for the Company or its shareholders. There is no
assurance that Health Canada will grant any license or ready to build letter to
the Company at any time, with respect to the Company s MMPR application.
The CNSX has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release.